It is known that the adhesion molecule ALCAM (CD166) mediates metastasis of malignant cells and organogenesis in embryos. We show here that embryonic day 8.5 (E8.5) murine yolk sac cells express ALCAM protein and that ALCAM expression can be used to define endothelial and cardiac precursors from hematopoietic precursors in E8.5 yolk sacs. ALCAM high+ cells exclusively give rise to endothelial and cardiac cells in matrigel assays but generate no hematopoietic colonies in methylcellulose assays. ALCAM low+ and ALCAMÀ populations predominantly give rise to hematopoietic cells in methylcellulose, but do not generate any cell clusters in matrigel. The ALCAM high+ population contains both Flk-1+ and Flk-1À cells. The former population exclusively contains endothelial cells whereas the latter give rise to cardiac cells when cultured on OP9 stromal cells. We also show that cardiac lineage marker genes such as Nkx-2.5, and the endothelial marker VE-cadherin are expressed in the ALCAM high+ fraction, whereas the hematopoietic marker GATA1 and Runx1 are expressed in the ALCAM low+/À fraction. However, we did not detect expression of the cardiac structural protein cTn-T in cells from yolk sac cells until these had had been differentiated on OP9 for 5 days. Altogether, these results indicate that cells retaining a potential to differentiate to the cardiac lineage are present in E8.5 yolk sacs and can be isolated as ALCAM high+, Flk-1À cells. Our report provides novel insights into the origin and differentiation process of cardiac cells in the formation of the circulatory system.
Introduction
The three distinct lineages that make up the circulatory system, blood, endothelial and cardiac cells are all derived from the lateral plate mesoderm. Prior to the commencement of definitive hematopoiesis in the aorta-gonad-mesonephros (AGM) region at E10.5, hematopoiesis is tightly coupled to yolk sac vasculogenesis in a process that is thought to occur through the differentiation of a common precursor known as the hemangioblast which is thought to migrate from the primitive streak to the yolk sac during the E7.0-7.5 period (Huber et al., 2004) . The early heart is thought to arise from the differentiation of embryonic precursors in a process that occurs independently from yolk sac hematopoiesis and vasculogenesis.
In contrast to the vasculogenesis in the yolk sac, the formation of the vessel network in embryonic tissues is thought to occur without accompanying hematopoiesis. Based on these observations, it is thought that the forma-tion of the circulatory systems in the yolk sac and the embryo occur independently, and that cardiac precursors reside only in embryos.
Hematopoietic and endothelial yolk sac precursors have been thoroughly characterized by a set of surface markers including CD41 (Ferkowicz et al., 2003) , Flk-1 (Nishikawa et al., 1998; Hirai et al., 2003) , VE-Cadherin (Nishikawa et al., 1998) , Tie2 (Ema et al., 2006) , CD45 and Ter119. We recently reported that ALCAM (CD166) is a useful cardiac surface marker at developmental stages between E8.5-E10.5 (Hirata et al., 2006) . However, with the exception of ALCAM no other surface markers have been identified for cardiac cells and the expression of genes such as Nkx-2.5 (Jamali et al., 2001; Tanaka et al., 1999) and GATA4 (Watt et al., 2004) have been use as an index of cardiogenic differentiation. We generated the monoclonal antibody ALCAM which specifically recognizes early cardiac cells (Hirata et al., 2006) . In the course of whole mount staining experiment with embryos from E7.0-E9.5, we noticed that some cells in the yolk sac were also stained with ALC-48 in addition to cardiac cells, which prompt us to explore the nature and possible function of these ALCAM positive cells in the yolk sac.
Here we report that a subset of E8.5 yolk sac cells retain cardiac potential and that these cells can be identified as ALCAM (CD166) positive/Flk-1À cells. The process of segregation and maturation of cardiac, blood and endothelial cells in the yolk sac at E8.5 will be discussed.
Results

ALCAM protein is expressed in the yolk sac
Expression of ALCAM was determined by whole mount immuno-staining of embryos and yolk sacs at E7.5-8.5. At E7.5 ALCAM protein is expressed exclusively in the yolk sac with no staining detected in any part of the embryo including the cardiac crescent ( Fig. 1A and B) . At E8.5 ALCAM expression is observed both in the yolk sac and the single chambered heart (Fig. 1C-H ). As we previously reported, the expression of ALCAM in the heart is observed in a developmental stage specific manner (Hirata et al., 2006) . Although ALCAM protein is detected in yolk sacs at E7.5, the morphology and distribution of the tissues that expresses ALCAM is unclear. However, at E8.5 ALCAM is expressed most strongly in a set of clusters of small cells associated with the yolk sac vasculature (Fig. 1H ).
2.2. Hematopoietic cells can be isolated from ALCAM low+/À fraction of E8.5 yolk sac cells E8.5 yolk sac cells can be fractionated into three populations (P3, P4, P5) according to cell size and granularity ( Fig. 2A) . Ter119 is predominantly expressed in the small cell population (P5) consistent with Ter119 being an erythroblast marker (Fig. 2C) . The majority of the cells in the P3 or P4 fractions do not express Ter119 ( Fig. 2B and D) . ALCAM positive (+) cells reside predominantly in the P4 fraction (Fig. 2B) .
About 2 · 10 4 cells from the four populations (P3, P4 ALCAM low+/À, P4 ALCAM high+ and P5), indicated in Figs. 2A and 3A, were seeded in methylcellulose to determine the number of hematopoietic precursor cells in each fraction. Cells with hematopoietic potential are present in both the P3 and the P4 ALCAM low+/À fractions, whereas the P4 ALCAM high+ and the P5 fractions generated only a very small number of hematopoietic colonies (Fig. 3B) . Ter119 is predominantly expressed in the small cell population (P5) which does not generate any colony in methylcellulose. These results indicate that P5 predominately consists of erythroblasts.
To explore the hematopoietic population in the yolk sac at E8.5 further, we looked for a surface molecule that can fractionate the hemogenic ALCAM low+/À population. Of the molecules tested, in agreement with previous findings (Ferkowicz et al., 2003) , we found that hematopoietic potential was only found in CD41+ cells which do not express ALCAM protein highly (Fig. 4) . Interestingly, all CD41 positive cells were either low or negative for ALCAM expression, which concurs with the results of the methylcellulose assays (Fig. 4). 2.3. Cardiogenic and/or vasculogenic potential is present in the ALCAM high+ fraction of E8.5 yolk sac cells
The fractions shown in Fig. 3B were seeded in matrigel to determine colony or cell cluster forming potential. As shown in Fig. 5A , cell clusters were generated only from the P4 ALCAM high+ fraction. ALCAM high+ cells gave rise to tube or lobe-like cell clusters ( Fig. 5B and C) . The tube-like, but not the lobe-like cell clusters can be stained with anti-Flk-1 antibody and Ac-LDL, suggesting that these clusters contain endothelial cells (Fig. 5E ). Interestingly, about one third of the clusters generated from the P4 ALCAM high+ fraction were lobe-like cell clusters and these exhibited spontaneous beating (Supplemental Video A). Beating cell clusters were harvested from the matrigel and stained with an antibody to the cardiac structural protein cardiac troponin T (cTn-T). All beating clusters stained positive for cTn-T (Fig. 5D) .
Interestingly, no cell clusters were generated from the P4 ALCAM low+/À, P3 or P5 fractions, in a manner reciprocal to the behavior in methylcellulose assays. These results suggest that common precursor(s) that give rise to both blood and endothelial cells, or blood and cardiac cells are not present in E8.5 yolk sacs.
Cardiac cells and endothelial cells can be separated by flk-1 expression
Since ALCAM high+ cells can give rise to both cardiac and endothelial cells, we looked for a secondary marker that can distinguish between the two lineages. Yolk sac cells were co-stained with a series of antibodies to surface molecules related to mesodermal differentiation to fractionate the ALCAM high+ population. Of the tested molecules, Tie-2 ( Fig. 6 ) and Flk-1 (Fig. 7) were found to separate the ALCAM+ fraction. The fractionated cells were seeded on OP9 and co-cultured for 7 days followed by staining with anti-cTn-T and anti-CD31 (PECAM-1) antibodies to determine the cardiac and endothelial potential of the sorted populations. ALCAM+ Tie-2À cells only gave rise to cardiac cells, whereas the ALCAM+ Tie-2+ fraction gave rise to both cardiac and endothelial cells ( Fig. 6B-E) .
Interestingly, cells in the ALCAM+ population, with cardiac or endothelial potential are clearly separated by Flk-1 expression (Fig. 7) . The ALCAM+ Flk-1+ population gave rise to CD31+ endothelial cells but never to cTn-T+ cells. In contrast, the ALCAM+ Flk-1À fraction gave rise only to cTn-T+ cardiac cells with no CD31+ cells detected. The same results were obtained when cultured yolk sac cells on PA6 cell line, although the frequency of generating cTn-T+ cardiac cells and endothelial cells was some two third of that on OP9. Beating cells sorted from the ALCAM+, Flk-1À fraction on OP9 prior to staining are shown in Supplemental Video B. A small proportion of the Tie2+ cells also expressed Flk1, whereas all Flk1+ cells express high levels of Tie2 (Fig. 7F ). We also employed PA6, MC3T3-E1 co-culture system to support the finding from OP9 co-culturing.
Taken together, our results suggest that cells retaining cardiac potential reside in the ALCAM high+ Flk-1À population, whereas the Flk-1+ population contains only cells with endothelial properties.
Yolk sac cells at E8.5 include lineage committed cells
To explore the lineage commitment and maturity of ALCAM high+ cells in E8.5 yolk sacs, the expression of several lineage markers was determined by quantitative RT-PCR (qRT-PCR). The cardiac lineage markers Nkx-2.5 as well as the endothelial marker VE-cadherin are expressed in ALCAM high+ cells, whereas ALCAM low+/À cells express hematopoitic markers such as GATA1 (Fig. 8 ). This is in agreement with the lineage potential of the ALCAM fractions as revealed by the methylcellulose, matrigel and OP9 co-culture assays. These results suggest that yolk sac cells at E8.5 contain a population of cells committed to the cardiac lineage. However, the expression of cardiac structural protein cTn-T in ALCAM high+ fraction was not detected by qRT-PCR (data not shown). ALCAM high+ E8.5 yolk sac cells were co-cultured on OP9 either for 1, 3 or 5 days, and stained with anit-cTn-T antibody to detect functional cardiac cells. Some of ALCAM+ cells from the yolk sac at E8.5 give rise to the cells expressing cTn-T on OP9 at day 5 of co-culturing (Fig. 8D ) and the cells with spontaneous beating (Supplementary Video). But ALCAM+ cells do not express cTn-T on OP9 at day 1 of co-culturing. All together these results suggest that although the yolk sac at E8.5 contains cells that are committed to the cardiac lineage (as indicated by Nkx-2.5 expression), these cells are not mature cardiomyocytes.
Discussion
This is the first report identifying cardiac lineage committed cells residing in the yolk sac. We show that hematopoietic and endothelial/cardiac precursors in E8.5 yolk sacs can be segregated by ALCAM expression. Although we show that ALCAM can be used to mark cells of the endothelial and cardiogenic lineages, ALCAM itself does not appear to be required for the development of these structures as ALCAM null mice are reported to be viable and fertile without any external morphological or cardiovascular abnormality (Weiner et al., 2004) . It is also intriguing that yolk sac cells that give rise to cardiac or endothelial cells can be further separated and isolated by the expression of Flk-1 within the ALCAM high+ fraction. Thus yolk sac cells that give rise to one of the three lineages, cardiac, endothelial and hematopoietic cells can be clearly isolated by the combination of the surface molecules ALCAM, Flk-1 and CD41.
The absence of any cells able to give rise to both hematopoietic and endothelial cells in any sorted fraction supports previous reports (Huber et al., 2004; Yokomizo et al., 2007; Choi et al., 1998 ) that a common precursor for hematopoietic and endothelial cells, the ''hemangioblast'', is absent from the yolk sac by E8.5. We also show that no common precursor for the endothelial and cardiac lineages is present in the yolk sac at this stage, as both lineages are clearly separated by the combination of Flk-1 and ALCAM expression. These findings indicate that the segregation of the three lineages has been already completed at latest by E8.5 in the yolk sac. To determine the duration Fig. 2A , cells harvested from E8.5 yolk sacs were fractionated into three populations (P3, P4, P5). Moreover, cells in P4 population were fractioned into two populations according to the ALCAM expression (A). Cells harvested from E8.5 yolk sacs were sorted and fractionated into following 4 populations; P3 ( Fig. 2A) , P4 ALCAM low/À (A), P4 ALCAM high+ (A), P5 ( Fig. 2A) . These four populations were applied to methylcellulose assay. that the ALCAM antigen serves as a marker for segregation of hematopoietic cells from cardiac/endothelial cells, the yolk sac cells from E7.5 and E9.5 were determined by flow cytometry. The isolation of viable single cell from the yolk sac at E7.5 was technically hard. Despite that the methylcellulose and matrigel assays using the yolk sac cells from E9.5 generated essentially the same result as they from E8.5 (data not shown), the percentage of ALCAM high+ cells in P3 + P4 cells decreased to 5-8% at E9.5. We confirm the segregation of three lineages takes place by E8.5.
Yolk sac cells committed to the hematopoietic lineage can be enriched by the ALCAM negative (À) surface phenotype and most ALCAM -cells express Tie-2 at a low level (Tie-2 low+). Tie-2 high+ cells also express ALCAM highly and can give rise to cardiac or endothelial, but not hematopoietic cells. Tie-2, although known as an endothelial marker, is also reported to be expressed on hematopoietic stem cells in the adult bone marrow (Arai et al., 2004) and primitive erythropoietic progenitors in extraembryonic tissues at E7.75. We can not deny the possibility that a hematopoietic organ resides in embryo at E8.5, hematopoietic cells in the yolk sac can be characterized by the expression of CD41 rather than Tie-2 in agreement with previous findings (Ferkowicz et al., 2003; Mikkola et al., 2003) . As we showed in Figs. 3 and 6 , all Tie-2 high+ cells from the yolk sac express ALCAM highly and have diverged from the hematopoietic lineage indicating that Tie-2 is no longer useful marker for primitive hematopoiesis by this stage. The segregation of endothelial and cardiac cells by Flk-1 expression alone in ALCAM high+ cells was unexpected, since Flk-1 knock-in experiment conducted by Sato's group showed that cardiomyocytes as well as endothelial cells are both derived from Flk-1+ cells (Motoike et al., 2003) and cardiac stem cell derived from embryonic stem cell is reported to express Flk-1, CD31 and VE-Cadherin when co-cultured on OP9 (Iida et al., 2005) . These reports showed that both embryonic cardiac cell and ES cellderived cardiac cell would have expressed a typical mesodermal marker Flk-1 during a progenitor stage and lost its expression as they commit to cardiomyocytes. As we generate cTn-T+ and beating cardiomyocytes on OP9 from ALCAM+ Flk-1À fraction, not from ALCAM+Flk-1+, yolk sac cells might contain predominantly committed cardiac cells. These results provide further evidence that the segregation of cardiac and endothelial lineages is completed in the yolk sac by E8.5.
Interestingly, the ALCAM+ population consists of two subpopulations that either express Tie-2 highly or not at all whereas ALCAMÀ cells appear to express Tie-2 at an intermediate level (Fig. 6 ). Both the ALCAM+ fractions contain cells that can give rise to cardiac cells, but we do not have any data to suggest a physiological difference between these two populations.
We, here, report the presence of cardiac lineage committed cells in E8.5 yolk sacs. The cardiac specification and maturation process in embryos have been studies for decades. Namely, presumptive heart cells originate in the early primitive streak, just posterior to Hensen's node and extend about halfway down its length (Colas et al., 2000; Redkar et al., 2001 ) at around E6.75 in the mouse. The presumptive heart cells migrate anteriorly between the endoderm and the ectoderm through the primitive streak (Linask and Lash, 1986) . These cells are called cardiac mesoderm cells and their migration ceases when they reach the lateral walls of the anterior gut tube. The anterior visceral endoderm (AVE) appears to provide the directionality of this migration (Schultheiss et al., 1995) as well as the final specification of the cardiac cells through BMP, FGF and Wnt signaling that is known to induce Nkx-2.5 in the cardiac mesoderm (Schneider and Mercola, 2001; Lough and Sugi, 2000; Brand, 2003) . Our analysis indicates that the yolk sac contains already ''committed'' cardiomyocytes expressing Nkx-2.5. This suggests that the yolk sac can support cardiac specification in mesodermal cells. Although it is possible that the yolk sac endoderm might be involved in this specification in a manner similar to the AVE in the embryo, cardiac maturation does not take place in the yolk sac as shown by the lack of cTn-T expression (Fig. 8B and C) .
The yolk sac will never contain a second heart, which means the yolk sac might produce an inhibitor or lack all the other signals required for the maturation of cardiac committed cells in yolk sac. At this moment we have no data that addresses the role of these cells in the yolk sac. It is possible that some of the presumptive cardiac primordial cells in the primitive streak migrate to the yolk sac together with other mesodermal cells. This might simply represent a leakage of cells to the wrong destination, or it is possible that these cells will provide some contribution to the heart by migration through the endothelial network. Such a migration might be mediated by ALCAM-ALCAM homophilic interactions (Lunter et al., 2005; Swart, 2002; Verma et al., 2005) since both the endothelial and the Nkx-2.5+ cells express ALCAM highly. Future cell tracing experiments may shed some light on these possibilities and the ultimate physiological role of these cardiac cells. Thus our report provides the possibility of studying both cardiac commitment and maturation process at a single cell level utilizing easily obtainable yolk sac cells at E8.5.
Experimental procedures
Mice, cells and flow cytometry
Mouse embryos between embryonic days (ED) E7.0 and E9.5 were isolated from ICR female mice (Shimizu Laboratory Supplies, Kyoto Japan). Cells from E8.5 yolk sacs were collected after dissociation in 0.05% Trypsin-EDTA (Invitrogen Corp., Carlsbad, CA) and stained with PI, biotinylated anti-ALCAM antibody ALC-48 (1:500, a monoclonal antibody generated by us), phycoerythrin (PE) conjugated anti-Flk-1antibody (AVAS 1:500, a gift from Dr. Nishikawa, RIKEN Center for Developmental Biology (CDB), Kobe, Japan), or PE/biotin conjugated anti-Tie-2 antibody (TEK4 1:500, eBioscience, San Diego, CA). Only live cells (as indicated by PI-negativity) were included in counts or sorted for further analysis. Biotinylated mAbs were detected using streptavidin-apophycocyanine Cy7 (APC-Cy7; BD Biosciences, Pharmingen, San Jose, CA). The cells were fractionated by the expression of ALCAM and Flk-1 with FACS Aria (BD Bioscience). OP9 stromal cells (RIKEN BioResource Center (BRC), Tsukuba, Japan) were maintained in aMEM supplemented with 20% FBS (JRH Biosciences, Lenexa, IA). All experimental protocols using animals were reviewed by the Animal Experimental Committee of The Foundation of Medical Research and Innovation (FBRI).
Methylcellulose assay and matrigel assay
About 2 · 10 4 cells sorted from yolk sacs at E8.5 were seeded in 1.1 ml of methylcellulose medium (M3434, Stem Cell Technologies Inc., Vancouver, Canada) in 3 cm dishes (BD Falcon 35-1008, BD Bioscience). Hematopoietic colonies were scored after 7 days of culture using a light microscope (Olympus IX71). About 2 · 10 4 sorted cells from yolk sacs were seeded in 100 ll of matrigel (BD Bioscience) in 96-well plates (BD Falcon 35-1172, BD Bioscience). Tube-like cell cluster formation was scored at culture day 7. The number of clusters was scored under a light microscope and beating clusters were recorded in the MPEG format.
4.3. Co-culture of fractionated E8.5 yolk sac cells on OP9 feeder layer For differentiation of E8.5 yolk sac cells into mature cardiac and/or endothelial colonies, E8.5 yolk sac cells were sorted and seeded on OP9 stromal cells in 48-well plates and co-cultured for 7 days with aMEMbased differentiation medium containing 10% FBS (Invitrogen) and 50 lmol/L 2-ME. 
Whole mount immuno-staining of embryos and cell staining
Whole-mount immuno-chemical staining was performed according to the protocols described by Takakura et al. (1997) with some modifications. In brief, murine embryos isolated from ICR female mice (Shimizu Laboratory Supplies) were fixed with 4% paraformaldehyde (PFA) overnight at 4°C, followed by bleaching with endogenous peroxidase blocking solution (methanol: dimethyl sulfoxide (DMSO): 30% H 2 O 2, 4:1:1) for 1 h at room temperature (RT). Then the specimens were rehydrated followed by blocking with PBS-MT (2% skimmed milk, 0.1%Triton X-100 in PBS) containing 1% sheep serum and 0.2% bovine serum albumin (BSA) for 1 h at RT. For fluorescent detection, the specimens were incubated with PBS-MT containing anti-ALCAM antibody (ALC-48, 1:1000 in use) overnight at 4°C followed by secondary staining with Alexa Fluor 594 rabbit antirat IgG (H + L) or Alexa Fluor 488 goat anti-rat IgG (H + L) (Molecular Probes) (1:1000 in use). Nuclear staining was performed with 2 lg/ml of 4 0 ,6-diamidino-2-phenylindole (DAPI). For DAB detection, 0.8 lg/ml of Peroxidase-conjugated donkey anti-rat IgG (H + L) (Jackson Immuno Research, West Grove, PA) in PBS-MT was employed as secondary antibody. DAB substrate detection kit (Vector Laboratories, Burlingame, CA) was employed in accordance with manufacturer's instruction and the enzymatic reaction was allowed to proceed until the desired color intensity was reached.
Live cell staining in matrigel was performed with Dil-Ac-LDL (Biomed Technology Inc. Stoughton, MA, 1:1000) and FITC-conjugated anti-Flk-1 antibody (AVAS 1:500). Fixed cell staining was performed with rat antimouse CD31 (TLD-3A12; BD Bioscience) (1:1000) or mouse anti-human cardiac Troponin-T antibody (NeoMarkers, Lab Vision, Fremont, CA) (1:100) after 4% PFA fixation, followed by detection with Alexa Fluor 594 rabbit anti-rat IgG (H + L) or Alexa Fluor 488 goat anti-mouse IgG (H + L) (Molecular Probes) (1:1000 in use). The specimens were subjected to microscopic observation with apparatus model IX71, SXZ12, BX51, IX81 and IX2-UCB (Olympus, Tokyo, Japan).
qRT-PCR analysis
Total RNA was extracted from yolk sac cells with RNeasy kits (Qiagen Valencia, CA). cDNA synthesis was performed with SuperScript II reverse transcriptase (Invitrogen) following the manufacturers instructions. cDNAs were amplified using rTaq polymerase (Takara Bio Inc., Otsu, Japan), using the following polymerase chain reaction (PCR) conditions: 94°C for 2 min followed by 30 cycles of amplification (denaturation at 94°C for 30 s, annealing at 60°C for 30 s, elongation at 72°C for 1 min), with a final incubation at 72°C for 7 min. Expression of marker genes was evaluated with real-time PCR following the protocol of SYBER Green methods (Applied Biosystems Japan, Tokyo Japan). The primer combinations used in real-time PCR assays are listed below. Quantitative PCR was performed with Prism 7000 (Applied Biosystem, Foster city, CA) in compliance with manufacturer's instruction. The raw data were standardized by the expression of the internal control glyceraldehyde-3-phosphate dehydrogenase (GAPDH). 
